Dysbiosis
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Persephone BiosciencesCA - San Diego
1 programMy Baby Biome: Infant Stool Samples for Microbiome Health (MBB)N/A1 trial
Active Trials
Allergy TherapeuticsUK - West Sussex
1 programREMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
Persephone BiosciencesMy Baby Biome: Infant Stool Samples for Microbiome Health (MBB)
Allergy TherapeuticsREMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
Clinical Trials (2)
Total enrollment: 630 patients across 2 trials
My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)
Start: Jul 2022Est. completion: Dec 2029430 patients
N/AActive Not Recruiting
NCT05622721Allergy TherapeuticsREMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
Start: May 2022Est. completion: May 2026200 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.